Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow
- PMID: 12042968
- DOI: 10.1007/s00330-001-1270-5
Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow
Abstract
The aim of this study was to differentiate normal, hypercellular, and neoplastic bone marrow based on its MR enhancement after intravenous administration of superparamagnetic iron oxides in patients with cancer of the hematopoietic system. Eighteen patients with cancer of the hematopoietic system underwent MRI of the spine before and after infusion of ferumoxides ( n=9) and ferumoxtran ( n=9) using T1- and T2-weighted turbo spin-echo (TSE) and short tau inversion recovery sequences (STIR). In all patients diffuse or multifocal bone marrow infiltration was suspected, based on iliac crest biopsy and imaging such as conventional radiographs, MRI, and positron emission tomography. In addition, all patients had a therapy-induced normocellular ( n=7) or hypercellular ( n=11) reconversion of the normal non-neoplastic bone marrow. The MRI data were analyzed by measuring pre- and post-contrast signal intensities (SI) of hematopoietic and neoplastic marrow and by calculating the enhancement as deltaSI(%) data and the tumor-to-bone-marrow contrast as contrast-to-noise ratios (CNR). Changes in bone marrow signal intensity after iron oxide administration were more pronounced on STIR images as compared with T1- and T2-weighted TSE images. The STIR images showed a strong signal decline of normal and hypercellular marrow 45-60 min after iron oxide infusion, but no or only a minor signal decline of neoplastic bone marrow lesions; thus, deltaSI% data were significantly higher in normal and hypercellular reconverted marrow compared with neoplastic bone marrow lesions ( p<0.05). Additionally, the contrast between focal or multifocal neoplastic bone marrow infiltration and normal bone marrow, quantified by CNR data, increased significantly on post-contrast STIR images compared with precontrast images ( p<0.05). Superparamagnetic iron oxides are taken up by normal and hypercellular reconverted bone marrow, but not by neoplastic bone marrow lesions, thereby providing significantly different enhancement patterns on T2-weighted MR images; thus, superparamagnetic iron oxides are useful to differentiate normal and neoplastic bone marrow and to increase the bone marrow-to-tumor contrast.
Similar articles
-
Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.Eur Radiol. 2006 Mar;16(3):598-607. doi: 10.1007/s00330-005-0045-9. Epub 2005 Nov 12. Eur Radiol. 2006. PMID: 16284770
-
Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.Acad Radiol. 2005 Sep;12(9):1190-7. doi: 10.1016/j.acra.2005.05.014. Acad Radiol. 2005. PMID: 16099684
-
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.AJNR Am J Neuroradiol. 2002 Apr;23(4):510-9. AJNR Am J Neuroradiol. 2002. PMID: 11950637 Free PMC article.
-
Hepatic MRI with SPIO: detection and characterization of focal liver lesions.Eur Radiol. 1998;8(7):1198-204. doi: 10.1007/s003300050535. Eur Radiol. 1998. PMID: 9724439 Review.
-
The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.Cancer Biomark. 2009;5(2):69-73. doi: 10.3233/CBM-2009-0579. Cancer Biomark. 2009. PMID: 19414923 Review.
Cited by
-
How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.Pediatr Radiol. 2022 Feb;52(2):354-366. doi: 10.1007/s00247-021-05098-5. Epub 2021 May 27. Pediatr Radiol. 2022. PMID: 34046709 Free PMC article. Review.
-
Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.Eur Radiol. 2020 Mar;30(3):1790-1803. doi: 10.1007/s00330-019-06569-y. Epub 2019 Dec 16. Eur Radiol. 2020. PMID: 31844962 Free PMC article.
-
Personalised Profiling of Innate Immune Memory Induced by Nano-Imaging Particles in Human Monocytes.Front Immunol. 2021 Aug 6;12:692165. doi: 10.3389/fimmu.2021.692165. eCollection 2021. Front Immunol. 2021. PMID: 34421901 Free PMC article.
-
Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.AJR Am J Roentgenol. 2023 Apr;220(4):590-603. doi: 10.2214/AJR.22.28453. Epub 2022 Oct 5. AJR Am J Roentgenol. 2023. PMID: 36197052 Free PMC article.
-
Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants.Radiology. 2012 Sep;264(3):803-11. doi: 10.1148/radiol.12112393. Epub 2012 Jul 19. Radiology. 2012. PMID: 22820731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical